Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234
来自 2 期临床试验的病理高危人乳头瘤病毒阴性头颈癌中 TP53 分析的进化作用评分:NRG 肿瘤放射治疗肿瘤组 0234
期刊:Advances in Radiation Oncology
影响因子:2.7
doi:10.1016/j.adro.2022.100989
Michikawa, Chieko; Torres-Saavedra, Pedro A; Silver, Natalie L; Harari, Paul M; Kies, Merrill S; Rosenthal, David I; Le, Quynh-Thu; Jordan, Richard C; Duose, Dzifa Y; Mallampati, Saradhi; Trivedi, Sanchit; Luthra, Rajyalakshmi; Wistuba, Ignacio I; Osman, Abdullah A; Lichtarge, Olivier; Foote, Robert L; Parvathaneni, Upendra; Hayes, D Neil; Pickering, Curtis R; Myers, Jeffrey N